Real world experience of trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK

被引：0
|
作者：
Cheng, Andy
Frank, Suzanne
Baines, Katherine
Nathan, Mark
Douglas, Rosalie V.
Sylva, Rushan
Ball, Jessica
Savva, Constantinos
Talbot, Thomas
Oikonomidou, Olga
Smith, Jenny
Thomson, Alastair
Ross, Felicity
Konstantis, Apostolos
Ainsworth, Nicola
Luciano, Pietro
Iyer, Pooja
Acharige, Shyamika
Rana, Shaikh
King, Judy
机构：
[1] Royal Free London NHS Fdn Trust, London, England
[2] Christie NHS Fdn Trust, Manchester, England
[3] Barts Hlth NHS Trust, London, England
[4] Guys & St Thomas NHS Trust London, London, England
[5] Belfast Hlth & Social Care Trust, Belfast, North Ireland
[6] Univ Hosp Leicester NHS Trust, Leicester, England
[7] Univ Hosp Bristol & Weston NHS Trust, Bristol, England
[8] Univ Hosp Southampton NHS Fdn Trust, Southampton, England
[9] Imperial Coll Healthcare NHS Trust, London, England
[10] Univ Edinburgh, Western Gen Hosp, NHS Lothian, Edinburgh, Scotland
[11] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle, Australia
[12] Royal Cornwall Hosp NHS Trust, Truro, England
[13] Hampshire Hosp NHS Fdn Trust, Basingstoke, England
[14] Princess Alexandra Hosp NHS Trust, Harlow, England
[15] Queen Elizabeth Hosp Kings Lynn NHS Trust, Kings Lynn, England
[16] Edinburgh Canc Ctr, Edinburgh, Scotland
[17] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, England
[18] Portsmouth Hosp Univ NHS Trust, Portsmouth, England
[19] Worcestershire Acute Hosp NHS Trust, Worcester, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1024
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer
    Wolff, Antonio C.
    Mcshane, Lisa M.
    Allison, Kimberly H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 829 - 831
  • [22] Clinical experience with trastuzumab in metastatic breast cancer
    Sousa, N.
    Domingues, N.
    Mauricio, J. M.
    Bento, M. J.
    da Silva, J. Leal
    EJC SUPPLEMENTS, 2005, 3 (02): : 132 - 132
  • [23] Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
    Perez, Jose
    Garrigos, Laia
    Gion, Maria
    Janne, Pasi A.
    Shitara, Kohei
    Siena, Salvatore
    Cortes, Javier
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 811 - 824
  • [24] Administration of trastuzumab deruxtecan in metastatic breast cancer patients with severe hepatic impairment
    Sun, Laura
    Moore, Gaybrielle
    Labatut, Annalise
    Meisel, Jane
    Kalinsky, Kevin
    Byers, Kristina
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2024, 16
  • [25] Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
    Rugo, H. S.
    Bianchini, G.
    Cortes, J.
    Henning, J-W
    Untch, M.
    ESMO OPEN, 2022, 7 (04)
  • [26] Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
    Henricks, Jonathan
    Haddad, Tyler
    Ahmed, Omair
    Schoenhals, Jonathan
    Kumar, Pavnesh
    Wilson, Ryan
    Ma, Jianing
    Wang, Jing Gennie
    Wert, Michael
    Esguerra, Vincent
    Bentley, Ian
    Johnson, Kai
    Stover, Daniel
    Jhawar, Sachin R.
    Gatti-Mays, Margaret
    Ho, Kevin
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [27] The role of trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment
    Wei, T.
    Wang, D.
    Yuan, P.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 948 - 949
  • [28] Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
    Nie, Tina
    Blair, Hannah A.
    TARGETED ONCOLOGY, 2023, 18 (03) : 463 - 470
  • [29] Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
    Bahceci, Aykut
    Paydas, Semra
    Ak, Naziye
    Ferhatoglu, Ferhat
    Saip, Pinar Mualla
    Seydaoglu, Gulsah
    Bilici, Mehmet
    Simsek, Melih
    Tekin, Salim Basol
    Calikusu, Zuleyha
    Yavuz, Sinan
    Sahin, Ahmet Bilgehan
    Cubukcu, Erdem
    Evrensel, Turkkan
    Degirmencioglu, Serkan
    Demiray, Atike Gokcen
    Yumuk, Perran Fulden
    Alan, Ozkan
    Cikman, Duygu Ilke
    Demirelli, Fuat Hulusi
    Kostek, Osman
    Gokyer, Ali
    Dogan, Mutlu
    Bal, Oznur
    Cakar, Burcu
    Gokmen, Erhan
    Yamac, Deniz
    Korkmaz, Taner
    Aliyev, Altay
    Keskin, Ozge
    Urvay, Semiha
    Buyuksimsek, Mahmut
    Karadeniz, Cemile
    Yildiz, Birol
    Cinkir, Havva Yesil
    Demir, Hacer
    Beypinar, Ismail
    Karacin, Cengiz
    Eser, Kadir
    Baykara, Meltem
    Kilickap, Saadettin
    Okutur, Kerem
    Bulut, Gulcan
    Alkan, Ali
    Arpaci, Erkan
    Pilanci, Kezban Nur
    Demir, Atakan
    Isik, Deniz
    Yildirim, Nilgun
    CANCER INVESTIGATION, 2021, 39 (6-7) : 473 - 481
  • [30] New approval: Trastuzumab-deruxtecan for metastatic breast cancer HER2+
    Minot-This, Marie-Sophie
    Bellesoeur, Audrey
    BULLETIN DU CANCER, 2021, 108 (09) : 783 - 784
12345